Aging and sexual health: getting to the problem (Q38738470)

6 September 2017

1 reference

title

Aging and sexual health: getting to the problem (English)

1 reference

6 September 2017

Serap Gur

4

1 reference

ORCID Public Data File 2021

Suresh C Sikka

series ordinal

2

object named as

Suresh C Sikka

1 reference

6 September 2017

3

Philip J Kadowitz

1 reference

6 September 2017

Ecem Kaya

1

1 reference

6 September 2017

publication date

6 March 2017

1 reference

6 September 2017

1 reference

6 September 2017

volume

20

1 reference

6 September 2017

issue

2

1 reference

6 September 2017

page(s)

65-80

1 reference

Sex and the heart: what is the role of the cardiologist?

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

The relationship of salivary testosterone and male sexual dysfunction in opioid-associated androgen deficiency (OPIAD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Obesity, dyslipidemias and erectile dysfunction: a report of a subcommittee of the sexual medicine society of North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Beneficial impact of exercise and obesity interventions on erectile function and its risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Erectile dysfunction severity as a risk predictor for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Erectile dysfunction and risk of clinical cardiovascular events: a meta-analysis of seven cohort studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Erectile dysfunction and cardiovascular events in diabetic men: a meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Penile doppler ultrasound in patients with erectile dysfunction (ED): role of peak systolic velocity measured in the flaccid state in predicting arteriogenic ED and silent coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Androgen regulation of prostate cancer: Where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

The correlation between metabolic syndrome and prostatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Medical management of erectile dysfunction in aging males: is it too late to treat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Tadalafil is efficacious and well tolerated in the treatment of erectile dysfunction (ED) in men over 65 years of age: results from Multiple Observations in Men with ED in National Tadalafil Study in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Erectile dysfunction in a Mediterranean country: results of an epidemiological survey of a representative sample of men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Changes in sexual function in middle-aged and older men: longitudinal data from the Massachusetts Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Attitudes of men with erectile dysfunction: a cross-national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Endothelial dysfunction and erectile dysfunction in the aging man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Morphological and functional evidence for the contribution of the pudendal artery in aging-induced erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Evaluation of vitamin E in the treatment of erectile dysfunction in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Posttranslational modification of constitutive nitric oxide synthase in the penis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Overexpression of arginase in the aged mouse penis impairs erectile function and decreases eNOS activity: influence of in vivo gene therapy of anti-arginase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

eNOS-uncoupling in age-related erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Pre-penile arteries are dominant in the regulation of penile vascular resistance in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Erectile dysfunction: the earliest sign of generalized vascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Sexual function of the ageing male

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Subtype specific regulation of human vascular alpha(1)-adrenergic receptors by vessel bed and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Mechanisms of penile fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Amelioration of penile fibrosis: myth or reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Comparative analysis of the penis corpora cavernosa in controls and patients with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Sexual dysfunction and the ageing male

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Effects of sense tankyrase transfection on smooth muscle cells of corpus cavernosum in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Effect of tankyrase 1 on autophagy in the corpus cavernosum smooth muscle cells from ageing rats with erectile dysfunction and its potential mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Erectile tissue molecular alterations with aging: differential activation of the p42/44 MAP Kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Rho-kinase inhibition improves erectile function in aging male Brown-Norway rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Sarcolemmal K(ATP) channels in ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Ageing causes cytoplasmic retention of MaxiK channels in rat corporal smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Testosterone for the aging male; current evidence and recommended practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Effects of Medical or Surgical Castration on Erectile Function in an Animal Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Identification of late-onset hypogonadism in middle-aged and elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

How to define hypogonadism? Results from a population of men consulting for sexual dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

How to recognize late-onset hypogonadism in men with sexual dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Testosterone deficiency causes penile fibrosis and organic erectile dysfunction in aging men. Evaluating association among Age, TDS and ED

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Aging, mitochondria and male reproductive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Changes in amount and intracellular distribution of androgen receptor in human foreskin as a function of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Sexual dysfunction in the elderly: age or disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Dose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Androgens play a pivotal role in maintaining penile tissue architecture and erection: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Clinical review 171: The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Aging and hormones of the hypothalamo-pituitary axis: gonadotropic axis in men and somatotropic axes in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Elevated levels of gonadotrophins but not sex steroids are associated with musculoskeletal pain in middle-aged and older European men

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Endocrinologic Control of Men's Sexual Desire and Arousal/Erection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

The relationships between sex hormones and sexual function in middle-aged and older European men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

The associations between serum sex hormones, erectile function, and sex drive: the Olmsted County Study of Urinary Symptoms and Health Status among Men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Male sexual function can be maintained without aromatization: randomized placebo-controlled trial of dihydrotestosterone (DHT) in healthy, older men for 24 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Longitudinal Relationships between Reproductive Hormones and Cognitive Decline in Older Men: The Concord Health and Ageing in Men Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Gene transfer of extracellular SOD to the penis reduces O2-* and improves erectile function in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Autophagy, organelles and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Effect of HO-1 cDNA-liposome complex transfer on erectile signalling of aged rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Effect of combination endothelial nitric oxide synthase gene therapy and sildenafil on erectile function in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Higher expression of mRNA and protein of insulin-like growth factor binding protein-3 in old rat penile tissues: implications for erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Gene transfer with a vector expressing Maxi-K from a smooth muscle-specific promoter restores erectile function in the aging rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

The successful long-term treatment of age related erectile dysfunction with hSlo cDNA in rats in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Insulin-like growth factor-1 restores erectile function in aged rats: modulation the integrity of smooth muscle and nitric oxide-cyclic guanosine monophosphate signaling activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Mesenchymal stem cells alone or ex vivo gene modified with endothelial nitric oxide synthase reverse age-associated erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Effect of muscle-derived stem cells on the restoration of corpora cavernosa smooth muscle and erectile function in the aged rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Stem cell treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Characterisation, prevalence, and consultation rates of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

The correlation between emotional distress and aging males' symptoms at a psychiatric outpatient clinic: sexual dysfunction as a distinguishing characteristic between andropause and anxiety/depression in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Erectile Dysfunction and Depression: Screening and Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Depression is correlated with the psychological and physical aspects of sexual dysfunction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Evaluation and treatment of erectile dysfunction in the aging male: a mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Erectile dysfunction: monitoring response to treatment in clinical practice--recommendations of an international study panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Erectile dysfunction in the elderly: an old widespread issue with novel treatment perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Sexual counseling in elderly couples

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Erection hardness: a unifying factor for defining response in the treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Effects of tadalafil treatment combined with physical activity in patients with low onset hypogonadism: results from a not-randomized single arm phase 2 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

International expert consensus conference on testosterone deficiency and its treatment held in Prague, Czech Republic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus - a series of case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

The effect of testosterone treatment on prostate histology and apoptosis in men with late-onset hypogonadism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Prevalence of erectile dysfunction in France: results of an epidemiological survey of a representative sample of 1004 men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Prevalence and predictors of sexual problems in men aged 75-95 years: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Sex after seventy: a pilot study of sexual function in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

A study of sexuality and health among older adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

The impact of age, body mass index and testosterone on erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Is there any relation between serum levels of total testosterone and the severity of erectile dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Taurine enhances the sexual response and mating ability in aged male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Intracavernosal injection of vascular endothelial growth factor improves erectile function in aged rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Epigallocatechin-3-gallate ameliorates erectile function in aged rats via regulation of PRMT1/DDAH/ADMA/NOS metabolism pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

A multicenter, double-blind, placebo-controlled trial to assess the efficacy of sildenafil citrate in men with unrecognized erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Retrospective analysis of the efficacy and safety of once-daily tadalafil in patient subgroups: men with mild vs moderate ED and aged <50 vs 50 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are naïve to PDE5 inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

The POTENT II randomised trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

The POTENT I randomized trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Efficacy and safety of avanafil for treating erectile dysfunction: results of a multicentre, randomized, double‐blind, placebo‐controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

A Randomized, Double‐Blind, Placebo‐Controlled Evaluation of the Safety and Efficacy of Avanafil in Subjects with Erectile Dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

An open-label, long-term evaluation of the safety, efficacy and tolerability of avanafil in male patients with mild to severe erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Efficacy and safety of mirodenafil, a new oral phosphodiesterase type 5 inhibitor, for treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Safety and efficacy of once daily administration of 50 mg mirodenafil in patients with erectile dysfunction: a multicenter, double-blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Efficacy and safety of oral SK3530 for the treatment of erectile dysfunction in Korean men: a multicenter, randomized, double-blind, placebo-controlled, fixed dose, parallel group clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Efficacy and tolerability of lodenafil carbonate for oral therapy in erectile dysfunction: a phase II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Efficacy and tolerability of lodenafil carbonate for oral therapy of erectile dysfunction: a phase III clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

A Randomized Open‐Label Trial with a Crossover Comparison of Sexual Self‐Confidence and Other Treatment Outcomes Following Tadalafil Once a Day Vs. Tadalafil or Sildenafil On‐Demand in Men with Erectile Dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Efficacy of once-daily administration of udenafil for 24 weeks on erectile dysfunction: results from a randomized multicenter placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Effects of daily low-dose treatment with phosphodiesterase type 5 inhibitor on cognition, depression, somatization and erectile function in patients with erectile dysfunction: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Efficacy and safety of once-daily dosing of udenafil in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Efficacy of udenafil for the treatment of erectile dysfunction up to 12 hours after dosing: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Real-Time PCR Study of Ang1, Ang2, Tie-2, VEGF, and KDR Expression in Human Erectile Tissue during Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

Effects of testosterone supplementation on prevention of age-related penile remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685538.2017.1295435

10.1080/13685538.2017.1295435

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference